If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

 

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBenchmark Holdings Regulatory News (BMK)

Share Price Information for Benchmark Holdings (BMK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 44.00
Bid: 44.00
Ask: 45.90
Change: -0.05 (-0.11%)
Spread: 1.90 (4.318%)
Open: 45.00
High: 45.00
Low: 44.00
Prev. Close: 45.00
BMK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update and Notice of Results

5 Dec 2017 07:00

RNS Number : 3602Y
Benchmark Holdings PLC
05 December 2017
 

5 December 2017

 

Information within this announcement is deemed by the Company to constitute inside information under the Market Abuse Regulations (EU) No. 596/2014.

Benchmark Holdings plc("Benchmark", the "Company" or the "Group")

Trading Update and Notice of Results

Benchmark, the aquaculture health, nutrition, and genetics business, provides the following trading update further to the announcement issued on 8 September 2017.

Financial Highlights

· Revenues of £138m, in line with market expectations (unaudited)

· Adjusted EBITDA of £10m (unaudited), ahead of the Company's guidance of £8.7m-£9.3m provided in the announcement of 8 September

· Improved result from previous guidance driven by positive trading in Genetics and Advanced Nutrition, and lower bonus accruals, partially offset by forex movements, Animal Health and lumpfish sales

· Net debt at year end of £24m

Divisional Highlights

Advanced Nutrition

· Overall, like for like revenues for the division grew by 21% (or by 8% on a constant currency basis over the prior year). Continued signs of recovery in key shrimp markets resulting in strong growth in sales of compound hatchery diets and health products, with Artemia sales similar to last year

Genetics

· Strong sales growth with a 49% increase (up 23% on a constant currency basis), driven by increasing demand for salmon products with sales in salmon eggs up on prior year in every major market

Animal Health (medicines and vaccines)

· Continued progress in pipeline of 46 products, of which five are in regulatory phase, and ten are in pre-regulatory development trials

Notice of Results

 

Benchmark will announce its full year results for the year ended 30 September 2017 on Tuesday 23 January 2018. An analyst meeting will be held on that day at 9.30am at the offices of MHP Communications, 6 Agar Street, London WC2N 4HN. To register your interest, please contact benchmark@mhpc.com.

 

Malcolm Pye, CEO, commented

"Benchmark has delivered organic growth and has achieved significant operational milestones, whilst continuing to invest in the development of its pipeline and infrastructure despite the challenges faced through the year. These, together, position us as a leader in one of the fastest growing segments in the food industry with great opportunities for further robust growth in the future."

-ENDS-

 

Enquiries:

 

Benchmark Holdings plc Tel: +44 (0)20 7920 3150

Malcolm Pye, CEO

Ivonne Cantu, Investor Relations Director

Rachel Aninakwah, Communications

 

Numis Tel: +44 (0)20 7260 1000

Michael Meade / Freddie Barnfield (NOMAD)

James Black (Corporate Broking)

 

MHP Tel: +44 (0)20 3128 8742

Katie Hunt Email: benchmark@mhpc.com

Reg Hoare

Alistair de Kare-Silver

 

Notes to Editors:

 

Benchmark challenges the status quo in aquaculture.

 

Since 2000, Benchmark has consistently worked to build a platform to serve its customers, helping food producers take control of their biological environment through the combination of genetics, nutrition, health and knowledge services. Through its in-depth knowledge of animal biology Benchmark is able to tackle the key issues facing producers primarily in the aquaculture sector.

 

The Company has proven distribution capabilities in high growth markets and operates internationally with R&D facilities, commercial farms, diagnostic laboratories, manufacturing sites, production facilities and commercial offices across 27 countries in five continents. As at 30 September 2017, Benchmark employed 952 people.

 

For further information on Benchmark please visit www.benchmarkplc.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLFFSLFILSIID
Date   Source Headline
7th May 20248:51 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings Plc
2nd May 20249:00 amRNSTotal Voting Rights
30th Apr 202410:55 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings Plc
26th Apr 20244:18 pmRNSForm 8.3 - BENCHMARK HOLDINGS PLC
26th Apr 20241:54 pmRNSNotice of Q2 and Interim Results
25th Apr 20247:00 amRNSForm 8.3 - BENCHMARK HOLDINGS PLC
23rd Apr 202410:44 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings Plc
23rd Apr 20247:00 amRNSRule 2.9 Announcement
22nd Apr 202410:42 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings plc
19th Apr 20249:23 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings plc
18th Apr 202410:37 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings Plc
17th Apr 20244:13 pmRNSFORM 8.3 - BENCHMARK HOLDINGS PLC
17th Apr 202410:27 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings Plc
16th Apr 20249:54 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings Plc
11th Apr 202410:51 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings Plc
8th Apr 202411:26 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings Plc
5th Apr 202410:38 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings plc
5th Apr 20249:23 amRNSForm 8.3 - Benchmark Holdings plc
28th Mar 202412:00 pmRNSTotal Voting Rights
22nd Mar 202411:51 amRNSForm 8.3 - Benchmark Holdings plc
22nd Mar 202410:52 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings Plc
22nd Mar 202410:33 amRNSBENCHMARK Holdings PLC
21st Mar 20249:58 amRNSForm 8.3 - Benchmark Holdings plc
21st Mar 20247:00 amRNSBlock Listing Six Monthly Return
20th Mar 202411:28 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings Plc
19th Mar 202410:01 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings Plc
15th Mar 202411:13 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings Plc
7th Mar 202411:26 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings Plc
7th Mar 20247:00 amRNSRule 2.9 Announcement
6th Mar 202410:36 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings Plc
5th Mar 202411:10 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings plc
4th Mar 20243:13 pmGNWForm 8.3 - [BENCHMARK HOLDINGS PLC - 01 03 2024] - (CGAML)
4th Mar 202411:22 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings plc
29th Feb 202411:19 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings Plc
29th Feb 20247:00 amRNSTotal Voting Rights
27th Feb 202411:24 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings Plc
26th Feb 202411:06 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings Plc
23rd Feb 202411:23 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings Plc
22nd Feb 20243:15 pmRNSForm 8.3 - BENCHMARK HOLDINGS PLC
21st Feb 202411:24 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings Plc
20th Feb 202411:40 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings Plc
19th Feb 202410:59 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings Plc
16th Feb 202410:26 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings plc
15th Feb 20247:00 amRNSQ1 Results
14th Feb 202411:37 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings Plc
8th Feb 20244:00 pmRNSResult of AGM
6th Feb 20244:08 pmRNSForm 8.3 - Benchmark Holdings PLC
6th Feb 20247:36 amRNSForm 8.3 - Benchmark Holdings PLC
5th Feb 20245:30 pmRNSRule 2.9 Announcement
5th Feb 20242:50 pmRNSForm 8.3 - Benchmark Holdings PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.